This month, Fairfield mourns the passing of two Fairfielders who lost their battle with Pancreatic cancer, including Jen Duguid Savader, a beloved teacher at Fairfield Woods Middle School. Their passing is a heartbreaking reminder of the urgency of early detection and the importance of equitable access to cancer screenings.
The Connecticut General Assembly has taken important steps in recent years to expand access to screenings for lung and breast cancer. This year, the Public Health Committee is considering a bill to provide screening for pancreatic cancer.
Among other things, SB 1191: An Act Establishing a Pancreatic Cancer Screening and Treatment Referral Program, promotes pancreatic cancer screening, detection, and treatment among unserved or underserved populations and educates the public about the importance of early detection.
In 2023, the Lung Cancer Early Detection and Treatment Referral Program (PA 23-204) was established through the Department of Public Health (DPH) to support residents ages 50 to 80, with a focus on high-risk populations.
In 2022, Connecticut passed An Act Concerning Required Health Insurance Coverage for Breast and Ovarian Cancer Susceptibility Screening (PA 22-90), which requires insurance plans to cover a broader range of breast and ovarian cancer screenings and treatments. This includes coverage for diagnostic and screening mammograms, MRIs, ultrasounds, biopsies, preventive mastectomies, reconstructive surgery, and genetic testing for cancer risk.
To learn more about where and how to get screened for cancer in Connecticut, including eligibility and insurance coverage, visit CT Department of Public Health – Cancer Screening.
- Pancreatic cancer is one of the deadliest forms of cancer, with a 5-year survival rate of just 13%.
- Lung and breast cancer remain two of the most commonly diagnosed cancers in Connecticut.
- Many cancers, when caught early through regular screenings, have significantly better outcomes.
Together, we can honor those we've lost by pushing for continued awareness, funding, and access to lifesaving screenings.
|